Healthy high growth potential

Results

1513

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1513 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$537.65-2.3%75.3%US$12.6bUS$679.6410.959.7%n/aPharmaceuticals & Biotech
AGP
€7.10-4.2%-7.2%€129.5m€8.5726.039.1%n/aCapital Goods
FWRY
ج.م19.303.6%55.8%ج.م65.7bج.م22.4524.727.3%n/aDiversified Financials
WAYS
SEK 39.502.6%-2.0%SEK 346.4mSEK 58.00210.278.5%0%Tech
688192
CN¥58.34-8.8%-21.3%CN¥28.3bCN¥83.0030.4105.9%n/aPharmaceuticals & Biotech
600183
CN¥125.10-14.9%222.0%CN¥306.1bCN¥137.0877.428.6%1.3%Tech
688300
CN¥127.38-19.6%156.6%CN¥31.0bCN¥151.00102.137.0%0.4%Materials
301358
CN¥66.017.8%100.0%CN¥51.1bCN¥115.2621.927.0%0.5%Capital Goods
MX1
AU$0.03-14.3%-53.8%AU$21.7mAU$0.151.3105.5%n/aHealthcare
002384
CN¥206.65-23.1%286.3%CN¥396.5bCN¥188.00184.673.1%0%Tech
688270
CN¥64.64-10.3%89.7%CN¥19.2bCN¥185.71128.885.5%0%Semiconductors
001389
CN¥160.50-18.0%147.0%CN¥76.0bCN¥248.6765.032.7%0.4%Tech
2455
NT$345.0010.2%158.4%NT$60.0bNT$404.70108.946.1%0.8%Semiconductors
RHM
€1,007.803.2%-43.3%€47.0b€1,697.8544.730.6%1.1%Capital Goods
LITE
US$829.7010.3%712.4%US$65.2bUS$1,104.89147.056.5%n/aTech
CRDO
US$228.270.7%132.0%US$41.7bUS$279.2990.127.7%n/aSemiconductors
NVDA
US$212.062.2%22.1%US$5.1tUS$302.8332.222.8%0.5%Semiconductors
SAUD3
R$15.02-3.1%30.6%R$43.9bR$16.6277.743.7%5.4%Healthcare
MOD
US$249.647.6%152.7%US$13.1bUS$340.86109.149.2%n/aCapital Goods
CORT
US$90.881.5%32.9%US$10.3bUS$106.00209.047.8%n/aPharmaceuticals & Biotech
AXSM
US$239.620.9%125.3%US$12.2bUS$282.5117.457.0%n/aPharmaceuticals & Biotech
CDR
zł233.000.5%-9.4%zł23.3bzł235.1345.129.7%0.4%Media
KEBNI B
SEK 1.06-1.4%-60.1%SEK 291.6mSEK 1.252.690.9%n/aTech
AV1
AU$0.078-3.7%-37.6%AU$74.1mAU$0.177.6108.4%n/aSoftware
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St